Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of Low Dose Injectable Progesterone in Triggering Ovulation
Sponsor: The General Authority for Teaching Hospitals and Institutes
Summary
The aim of this study is to evaluate the role of low dose injectable progesterone in triggering ovulation.
Official title: Role of Low Dose Injectable Progesterone in Triggering Ovulation: A Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
20 Years - 35 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-04-15
Completion Date
2025-08-01
Last Updated
2025-04-16
Healthy Volunteers
No
Conditions
Interventions
Progesterone
Women will receive low dose progesterone 5 mg intramuscularly as a study group. (Letrozole 2.5 mg/day will be given from cycle day 3 onwards for only 5 days).
Placebo
Women will receive placebo as a control group. (Placebo 2.5 mg/day will be given from cycle day 3 onwards for only 5 days).
Locations (1)
Teaching Hospitals and Institutes
Cairo, Egypt